Cyathane diterpenes from Sarcodon cyrneus and evaluation of their activities of neuritegenesis and nerve growth factor production

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 8, 2007, Pages 2878-2882

  Marcotullio, Maria Carla ^a   Pagiotti, Rita ^a   Maltese, Federica ^a   Oball Mond Mwankie, Gildas Norbert ^a   Hoshino, Tomohiro ^b   Obara, Yutaro ^b   Nakahata, Norimichi ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Cyathane diterpenes; Cyrneine C; Cyrneine D; Glaucopine C; Neurite outgrowth; NGF expression; PC12; Sarcodon cyrneus

Indexed keywords

CYRNEINE A; CYRNEINE B; CYRNEINE C; CYRNEINE D; DITERPENE; GLAUCOPINE C; NERVE GROWTH FACTOR; PLANT EXTRACT; SCABRONINE G METHYLESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTOMA CELL; CELL STRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MUSHROOM; NERVE FIBER GROWTH; NONHUMAN; PROTEIN SYNTHESIS REGULATION; RAT; SARCODON CYRNEUS; SPECTROSCOPY;

AGARICALES; ANIMALS; CELLS, CULTURED; CHROMATOGRAPHY, THIN LAYER; DITERPENES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR CONFORMATION; NERVE GROWTH FACTORS; NEURITES; PC12 CELLS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

BASIDIOMYCOTA; SARCODON;

EID: 33947095604     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.02.019     Document Type: Article

References (12)

1. Hirota M., Moritura K., and Shibata H. Biosci. Biotechnol. Biochem. 66 (2002) 179
2. Kamo T., Tmura Y., Hagio T., Makabe H., Shibata H., and Hirota M. Biosci. Biotechnol. Biochem. 68 (2004) 1362
3. Curini A., Maltese F., Marcotullio M.C., Menghini L., Pagiotti R., Rosati O., Altinier G., and Tubaro A. Planta Med. 71 (2005) 194
4. Marcotu M.C., Pagiotti R., Campagna V., Maltese F., Fardella G., Altinier G., and Tubaro A. Nat. Prod. Res. 20 (2006) 917
5. Kita T., Takaya Y., Oshima Y., Ohta T., Aizawa K., Hirano T., and Inakuma T. Tetrahedron 54 (1998) 1877
6. Obara Y., Nakahata N., Kita T., Takaya Y., Kobayashi H., Hosoi S., Ciuchi F., Ohta T., Oshima Y., and Ohizumi Y. Eur. J. Pharmacol. 370 (1999) 79
7. Obara Y., Kobayashi H., Ohta T., Ohizumi Y., and Nakahata N. Mol. Pharmacol. 59 (2001) 1287
8. Marcotu M.C., Pagiotti R., Maltese F., Obara Y., Hoshino T., Nakahata N., and Curini M. Planta Med. 72 (2006) 819
9. Obara, Y.; Hoshino, T.; Marcotullio, M. C.; Pagiotti, R.; Nakahata, N. Life Sci. in press.
10. Rittner et al. reported that electronegative substituents invariably shield the δ-carbon atom by 1-2 ppm, and this effect has been attributed to linear electric field effects. de Oliveira P.R., Tasic L., Rocco S.A., Rittner R. Magn. Reson. Chem. 44 (2006) 790 and references cited therein
11. Kawagishi H., Shimada A., Shirai R., Okamoto K., Ojima F., Sakamoto H., Ishiguro Y., and Furukawa S. Tetrahedron Lett. 35 (1994) 1569
12. Obara Y., Aoki T., Kusano M., and Ohizumi Y. J. Pharmacol. Exp. Ther. 301 (2002) 803